Drugs / Artemisiae argyi folium 95% ethanol ext.(20→1)
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03437785 Comparator | Jan → Oct 2018 | gastritis | Chong Kun Dang Pharmaceutical | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Artemisiae argyi folium 95% ethanol ext.(20→1) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03437785 ↗ |
| Known as | Stillen | “100 mg of rebamipide, 60 mg of Artemisiae argyi folium 95% ethanol ext. (20⟶ 1) (Stillen; Dong-A ST Co., Ltd., Seoul, Korea), or placebo for 2 weeks, respectively.” PMID 40255536 ↗ Apr 2025 |